ArticleCancer immunology, immunotherapy : CII2024

Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy.

Zongliang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.